ReviewAntioxidants (Basel, Switzerland)2026
Antioxidants as a Link Between Diabetes and Potential Plant-Based Therapies.
Review in Antioxidants (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The pathogenesis and advancement of diabetes mellitus and its associated complications are heavily driven by oxidative stress (OS). It happens when the body produces excessive amounts of reactive oxygen and nitrogen species (RONS). This causes cell damage and leads to chronic health issues, prompting scientific interest in antioxidant-based treatments. In the context of chronic diseases, such as diabetes, the search for new natural bioactive compounds is of particular importance. Within the realm of traditional healthcare, Ayurveda commands significant scientific interest. Botanical materials in the Ayurvedic tradition frequently demonstrate a wide array of physiological benefits, including (among others) hypoglycaemic and antioxidant effects. Because numerous contemporary medications trace their origins back to natural compounds-with metformin serving as a primary example-investigating these traditional botanicals could be instrumental in identifying novel pharmacological treatments. This review focuses on three traditionally used for diabetes: bitter melon (
Indexed as
Identifiers
42792245What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.